Synopsys, Inc. $SNPS Stock Acquired by Douglas Lane & Associates LLC

Douglas Lane & Associates LLC grew its stake in shares of Synopsys, Inc. (NASDAQ:SNPS) by 18.9% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 94,949 shares of the semiconductor company’s stock after acquiring an additional 15,077 shares during the quarter. Douglas Lane & Associates LLC’s holdings in Synopsys were worth $41,297,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in the stock. LifeGoal Investments LLC lifted its position in shares of Synopsys by 73.2% during the 3rd quarter. LifeGoal Investments LLC now owns 783 shares of the semiconductor company’s stock valued at $341,000 after buying an additional 331 shares in the last quarter. Stableford Capital II LLC purchased a new stake in Synopsys in the 3rd quarter worth approximately $1,344,000. Green Alpha Advisors LLC raised its stake in Synopsys by 56.6% during the 3rd quarter. Green Alpha Advisors LLC now owns 802 shares of the semiconductor company’s stock worth $349,000 after acquiring an additional 290 shares during the period. Farther Finance Advisors LLC raised its stake in Synopsys by 22.1% during the 3rd quarter. Farther Finance Advisors LLC now owns 4,522 shares of the semiconductor company’s stock worth $1,967,000 after acquiring an additional 817 shares during the period. Finally, CoreCap Advisors LLC boosted its position in shares of Synopsys by 129.1% in the third quarter. CoreCap Advisors LLC now owns 536 shares of the semiconductor company’s stock worth $233,000 after purchasing an additional 302 shares during the period. 85.47% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

SNPS has been the topic of several recent analyst reports. Zacks Research upgraded shares of Synopsys from a “hold” rating to a “strong-buy” rating in a research report on Friday, October 2nd. Robert W. Baird raised shares of Synopsys from a “neutral” rating to an “outperform” rating and increased their price objective for the company from $558.00 to $560.00 in a report on Thursday, August 27th. BNP Paribas Exane upgraded Synopsys from an “underperform” rating to a “neutral” rating and set a $420.00 price objective for the company in a research report on Thursday, September 24th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $640.00 target price on shares of Synopsys in a research report on Thursday, October 1st. Finally, KeyCorp lifted their price objective on Synopsys from $600.00 to $605.00 and gave the stock an “overweight” rating in a research note on Thursday, October 1st. One investment analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $584.11.

Trending Headlines about Synopsys

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Bank of America reiterated its Buy rating and $600 price target, citing Synopsys’ AI-driven growth prospects, collaboration with OpenAI and planned share repurchases. The target implies additional upside from recent trading levels. Bank of America Synopsys Rating
• Positive Sentiment: Synopsys’ expanding relationships with OpenAI, Amazon and Nvidia reinforce its position as a key provider of electronic-design-automation software as AI makes semiconductor development more complex. Nvidia’s investment and planned agentic AI design workflows add credibility to the growth thesis. Nvidia Partner Strong Buy Endorsement
• Positive Sentiment: The company’s recently authorized $1 billion buyback, equivalent to as much as 1.1% of outstanding shares, could support earnings per share and signal management’s confidence in the long-term value of SNPS.
• Neutral Sentiment: Synopsys reportedly plans to explore working with Chinese AI laboratories on chip-design technology. The opportunity could broaden its addressable market, but geopolitical restrictions and regulatory uncertainty may limit the commercial benefits. Synopsys Chinese AI Lab Report
• Negative Sentiment: Insiders continue to sell shares, including Janet Lee’s sale of 1,144 shares worth approximately $575,000 and a larger sale by Sudhindra Kankanwadi. While such transactions do not necessarily reflect weaker business expectations, they can create a short-term sentiment overhang. Synopsys Insider Selling
• Negative Sentiment: At roughly 89 times earnings and near its 52-week high, SNPS faces elevated expectations. Analysts remain broadly bullish, but concerns about valuation, slowing EDA growth and acquisition-related debt could make further gains more difficult. Can Synopsys Stock Drop From Here?

Insider Activity

In related news, insider Aart de Geus sold 25,000 shares of Synopsys stock in a transaction dated Monday, August 31st. The shares were sold at an average price of $441.76, for a total transaction of $11,044,000.00. Following the completion of the transaction, the insider directly owned 120,421 shares of the company’s stock, valued at approximately $53,197,180.96. The trade was a 17.19% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,604 shares of the company’s stock in a transaction dated Tuesday, September 15th. The shares were sold at an average price of $374.88, for a total transaction of $5,474,747.52. Following the transaction, the chief executive officer owned 76,865 shares in the company, valued at $28,815,151.20. The trade was a 15.97% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 102,559 shares of company stock worth $44,607,141. 0.56% of the stock is currently owned by insiders.

Synopsys Trading Up 1.8%

Shares of NASDAQ:SNPS traded up $8.82 during trading on Friday, reaching $506.57. The company’s stock had a trading volume of 607,778 shares, compared to its average volume of 2,036,413. The stock has a market capitalization of $97.08 billion, a PE ratio of 89.58, a price-to-earnings-growth ratio of 2.05 and a beta of 1.21. Synopsys, Inc. has a 12 month low of $362.55 and a 12 month high of $539.48. The company has a current ratio of 1.34, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29. The firm’s 50 day simple moving average is $417.52 and its two-hundred day simple moving average is $438.50.

Synopsys (NASDAQ:SNPS) last issued its quarterly earnings data on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.67 by $0.24. The business had revenue of $2.48 billion for the quarter, compared to the consensus estimate of $2.44 billion. Synopsys had a return on equity of 6.24% and a net margin of 11.43%.The company’s quarterly revenue was up 42.4% compared to the same quarter last year. During the same period in the prior year, the business posted $3.39 earnings per share. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. On average, research analysts predict that Synopsys, Inc. will post 10.97 EPS for the current fiscal year.

Synopsys declared that its Board of Directors has initiated a stock buyback plan on Monday, October 5th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the semiconductor company to reacquire up to 1.1% of its stock through open market purchases. Stock buyback plans are usually a sign that the company’s board of directors believes its shares are undervalued.

Synopsys Company Profile

Synopsys, Inc is a technology company that develops electronic design automation (EDA) software, semiconductor intellectual property (IP), and software tools used to design, verify, and manufacture advanced electronic systems. Its solutions support the development of semiconductors, systems-on-chip, and electronic products across the design cycle, from initial specification and architecture through testing and production.

The company’s offerings include digital and custom integrated-circuit design tools, simulation and verification software, physical design and signoff products, and semiconductor IP such as processor cores, interface technologies, and foundational components.